









Markets
/
Stocks
/
nasdaq-prqr
/

ProQR Therapeutics NV

PRQR

View Detailed Chart

2.070USD

-0.010-0.48%

Market hours （ET）Quotes delayed by 15 min

222.96MMarket Cap

LossP/E TTM



ProQR Therapeutics NV

2.070

-0.010-0.48%

Overview Company Financials

Financials

Intraday

30m

Today

-0.48%

5 Days

-7.17%

1 Month

-5.05%

6 Months

-8.00%

Year to Date

-21.89%

1 Year

+16.29%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 9 analysts

BUY

Current Rating

9.000

Target Price

332.69%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

ProQR Therapeutics NV

PRQR

CRISPR Therapeutics AG

CRSP

Ionis Pharmaceuticals Inc

IONS

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(6)

Neutral(2)

Buy(2)

Indicators

Sell(2)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.086

Neutral

RSI(14)

44.562

Neutral

STOCH(KDJ)(9,3,3)

10.047

Oversold

ATR(14)

0.140

Low Volatility

CCI(14)

-158.556

Sell

Williams %R

90.909

Oversold

TRIX(12,20)

0.262

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

2.148

Sell

MA10

2.202

Sell

MA20

2.260

Sell

MA50

2.035

Buy

MA100

1.767

Buy

MA200

2.332

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide and for the treatment of Leber’s congenital amaurosis (LCA).

Ticker SymbolPRQR

CompanyProQR Therapeutics NV

CEOMr. Daniel Anton de Boer

Websitehttps://www.proqr.com/